News
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants.
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback